IGFBP5 and breast cancer: IGFBP5 expression was markedly decreased upon the acquisition of resistance to tamoxifen in MCF-7 breast cancer cells [26], and its suppression was suggested to be a mechanism of cisplatin resistance in esophageal squamous cell carcinoma [27].